作者
Yuanyuan Liu, J Bryce Jarman, Yen S Low, Hannah E Augustijn, Steven Huang, Haoqing Chen, Mary E DeFeo, Kazuma Sekiba, Bi-Huei Hou, Xiandong Meng, Allison M Weakley, Ashley V Cabrera, Zhiwei Zhou, Gilles van Wezel, Marnix H Medema, Calyani Ganesan, Alan C Pao, Saurabh Gombar, Dylan Dodd
发表日期
2023/8/3
期刊
Cell
卷号
186
期号
16
页码范围
3400-3413. e20
出版商
Elsevier
简介
Approximately 15% of US adults have circulating levels of uric acid above its solubility limit, which is causally linked to the disease gout. In most mammals, uric acid elimination is facilitated by the enzyme uricase. However, human uricase is a pseudogene, having been inactivated early in hominid evolution. Though it has long been known that uric acid is eliminated in the gut, the role of the gut microbiota in hyperuricemia has not been studied. Here, we identify a widely distributed bacterial gene cluster that encodes a pathway for uric acid degradation. Stable isotope tracing demonstrates that gut bacteria metabolize uric acid to xanthine or short chain fatty acids. Ablation of the microbiota in uricase-deficient mice causes severe hyperuricemia, and anaerobe-targeted antibiotics increase the risk of gout in humans. These data reveal a role for the gut microbiota in uric acid excretion and highlight the potential for …
引用总数
学术搜索中的文章